Foundation Medicine: When making treatment decisions, knowledge is power
An advanced cancer diagnosis can change your life. You and your loved ones may feel overwhelmed with questions.
If you don’t know where to start when thinking about treatment options, there’s something you can do. Start With Step One—ask your doctor about the Foundation Medicine testing options, including the
Foundation Medicine tests use comprehensive genomic profiling, also known as CGP, to find information in your tumor’s DNA that may help your doctor identify a personalized cancer treatment plan that is right for you.
Understanding your tumor’s DNA may inform the treatment options available to you. Learn more in the video.
Customer Service:
Email:
Patient Support:
Email:
Tel:
Fax:
Legal statement policy
FoundationOne®CDx, FoundationOne®Liquid CDx, and FoundationOne®Heme are next-generation sequencing services performed by Foundation Medicine, Inc. at laboratories in the USA.
Hoffmann-La Roche Limited markets these services in Canada under an exclusive license from Foundation Medicine, Inc. These services were developed and their performance characteristics determined by Foundation Medicine. As in-house laboratory-developed tests, the services have not been submitted to Health Canada for evaluation and are not subject to Health Canada approval. Reports generated from these services are prepared by Foundation Medicine, without Hoffmann-La Roche Limited’s involvement, and may include scientific information about experimental medicinal products or uses that are not approved or available in Canada.
This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding a Roche product, please email [email protected] or call 1-877-273-3433. You can also report adverse events relating to any product to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.
This website contains materials intended only for residents of Canada, and may contain product details or information not available or valid outside of Canada. We accept no responsibility for users outside of Canada accessing portions of this website which may be invalid or non-compliant with the laws, regulations or standards of the user’s home country.